The FRAXA Drug Validation Initiative (FRAXA-DVI) provides speedy, cost-effective, objective preclinical testing to validate investigational and repurposed compounds for Fragile X. The post FRAXA Drug Validation Initiative (FRAXA-DVI) appeared first on FRAXA Research Foundation - Finding a Cure for Fragile X Syndrome.
